Willard Stephen H — SEC insider filings

SEC reporting owner CIK 1325232. 6 insider filings on record with FilingPulse; latest filed 2026-10-05.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2022-12-19 to 2026-10-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NRX Pharmaceuticals, Inc. (NRXP)CHIEF EXECUTIVE OFFICER, Director11 leg · 50,000 sh · $58,500——
Longeveron Inc. (LGVN)Chief Executive Officer5——8

Insider filings — Willard Stephen H

FiledFormIssuerReported transactionsSource
2026-10-054Longeveron Inc. (LGVN)Tax withholding (F): 1,987 @ $2.59EDGAR
2026-07-064Longeveron Inc. (LGVN)Tax withholding (F): 18,046 @ $0.73EDGAR
2026-05-054Longeveron Inc. (LGVN)Grant/award (A): 500,000 @ $0EDGAR
2026-04-034Longeveron Inc. (LGVN)Tax withholding (F): 4,740 @ $1.12EDGAR
2026-03-134Longeveron Inc. (LGVN)Grant/award (A): 200,000 @ $0 · Tax withholding (F): 105,533 @ $0.55 · Grant/award (A): 200,000 @ $0 · Grant/award (A): 200,000 (derivative) @ $0EDGAR
2022-12-194NRX Pharmaceuticals, Inc. (NRXP)Purchase (P): 50,000 @ $1.17EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1325232 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs